Clinical question: How to manage symptoms of hypogonadism in patients after androgen abuse?

Androgen abuse is relatively common amongst young (amateur) bodybuilders. After cessation, the hypothalamic‐pituitary‐gonadal (HPG) axis—which has been suppressed by the androgens—needs time to recover. The endogenous testosterone production often recovers within 3 months, however, prolonged or permanent post‐androgen abuse hypogonadism (PPAAH) has been described. There is no widely accepted definition nor is its pathogenesis completely elucidated. To date it is a subject of debate whether PPAAH is a separate entity, reflecting irreversible damage to essential components of the HPG axis inflicted by long‐term exposure to high doses of androgens. Alternately, it may be the result of longer than expected suppressive effects of androgen depots, undisclosed ongoing androgen abuse or undiagnosed unrelated disorders. Due to the lack of scientific evidence, the management of PPAAH is challenging. By combining clinical experience with evidence from the recent literature, a suggested outline of the management of androgen‐abuse‐induced hypogonadism are given.

[1]  L. V. van Loon,et al.  Undeclared Doping Substances are Highly Prevalent in Commercial Sports Nutrition Supplements. , 2021, Journal of sports science & medicine.

[2]  N. Jørgensen,et al.  Serum insulin-like factor 3 levels are reduced in former androgen users suggesting impaired Leydig cell capacity. , 2021, The Journal of clinical endocrinology and metabolism.

[3]  M. den Heijer,et al.  Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. , 2021, Human reproduction.

[4]  W. de Ronde,et al.  Anabolic androgenic steroid abuse in young males , 2020, Endocrine connections.

[5]  B. Venhuis,et al.  Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids , 2020, Scandinavian journal of medicine & science in sports.

[6]  David Handelsman,et al.  Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men. , 2020, The Journal of clinical endocrinology and metabolism.

[7]  M. L. Jørstad,et al.  Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires , 2019, Substance Abuse Treatment, Prevention, and Policy.

[8]  S. Bhasin,et al.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. , 2015, Addiction.

[9]  C. S. Andreassen,et al.  The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. , 2014, Annals of epidemiology.

[10]  David Handelsman.  Androgen misuse and abuse. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[11]  J. Kaufman,et al.  In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. , 2006, The Journal of clinical endocrinology and metabolism.

[12]  David Handelsman,et al.  Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis , 2006, The Lancet.

[13]  D. Grobbee,et al.  Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. , 2005, The Journal of clinical endocrinology and metabolism.